← Back
Data updated: Mar 29, 2026
HERITAGE
CardiovascularGastroenterologyInfectious Disease
Generics
HERITAGE is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Infectious Disease.
1978
Since
32
Drugs
-
Trials
318
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
NYSTATIN 2026-02-05
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 33%
3 drugs
Gastroenterology 22%
2 drugs
Infectious Disease 22%
2 drugs
Metabolic 11%
1 drugs
Neurology 11%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Merck big-pharma
Infectious Disease, Cardiovascular, Metabolic
Novo Nordisk big-pharma
Metabolic, Cardiovascular, Infectious Disease, Neurology
Johnson & Johnson big-pharma
Infectious Disease, Cardiovascular, Metabolic
AZURITY specialty
Cardiovascular, Neurology, Metabolic, Infectious Disease
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology, Infectious Disease
Active (19)
TRANEXAMIC ACID TEMOZOLOMIDE AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE VENLAFAXINE HYDROCHLORIDE SERTRALINE HYDROCHLORIDE LEFLUNOMIDE OCTREOTIDE ACETATE GLYBURIDE AND METFORMIN HYDROCHLORIDE PENTOXIFYLLINE PAROMOMYCIN SULFATE ACYCLOVIR GLYBURIDE BACLOFEN DESIPRAMINE HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE DOXYCYCLINE NYSTATIN DOXYCYCLINE HYCLATE HYDROCHLOROTHIAZIDE
Discontinued (13)
Company Info
- First Approval
- 1978-01-20
- Latest
- 2025-10-24
- Applications
- 37